Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
217.50    1.00 (0.46%)
Bid:
215.00
Ask:
220.00
Spread: 5.00 (2.326%)
Market Cap: £148.65m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Members' Agent's Agreements

5 Mar 2014 11:30

RNS Number : 5842B
Helios Underwriting Plc
05 March 2014
 



5 March 2014

 

Helios Underwriting plc

("HUW" or the "Company")

 

Members' Agent's Agreements

 

In recent years, the Company has acquired a number of limited liability underwriting vehicles ("LLVs") and consequently its underwriting capacity has grown to approximately £20 million. As a result of these acquisitions, the Company inherited a number of individual members' agency agreements with Hampden Agencies Ltd ("HAL"). Under these arrangements, separate fees were charged to each individual vehicle, together with a profit commission on a sliding scale from 1% of net profit (where the net profit was 1%) up to a maximum of 10% of net profit (where the net profit was 10% or more). Having consolidated the ownership of the LLV's, the Company has been able to benefit from the common ownership provisions set out in HAL's fee structure. With effect from 1 January 2014, the Company has agreed with HAL an annual fee based purely on underwriting capacity and calculated as £50,000 plus 0.2% of underwriting capacity in excess of £10 million; based on the Company's current 2014 underwriting capacity, this would amount to a total HAL fee for 2014 of approximately £70,000. Under the previous fee arrangements, the fee payable in relation to the Company's current 2014 capacity would have been approximately £95,000, excluding the profit commission which for each of the 2011 and 2012 underwriting years is estimated to be in the order of £50,000 (an estimate for 2013 is not yet available).

 

HAL is deemed to be a related party of the Company as its parent company, Hampden Capital plc (which owns 100% of HAL's ordinary shares), holds approximately 12% of the Company's ordinary shares. The Company's directors (with the exception of Jeremy Evans who is a director of, and has an interest in a small shareholding (under 1%) in, Hampden Capital plc and Nigel Hanbury who is a small shareholder (under 1%) in Hampden Capital plc) consider, having consulted with its nominated adviser, that the terms of the transaction are fair and reasonable insofar as its shareholders are concerned.

 

 

 

 

For further information please contact:

 

HUW

 

Nigel Hanbury

nigel.hanbury@huwplc.com

Smith & Williamson Corporate Finance

 

David Jones

020 7131 4000

 

About Helios Underwriting

HUW provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). For further information please visit www.huwplc.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRBBGDXUDGBGSU
Date   Source Headline
12th Dec 20227:00 amRNSResult of Open Offer
24th Nov 202212:54 pmRNSReplacement - Result of Placing and Subscription
24th Nov 20227:00 amRNSResult of Placing and Subscription
23rd Nov 20224:45 pmRNSFundraising to raise up to approximately £13.5m
29th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSQuarterly Syndicate Mid Point Forecasts
29th Jun 20221:13 pmRNSResult of AGM
1st Jun 20222:31 pmRNSPosting of Annual Report and Notice of AGM
27th May 20227:00 amRNSFinal Results
23rd May 20229:10 amRNSQuarterly Syndicate Mid Point Forecasts
8th Apr 20227:00 amRNSPCA Shareholding
1st Apr 20227:00 amRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSSyndicate Mid Point Forecasts and Estimate of NAV
4th Mar 20227:00 amRNSDirector/PDMR Shareholding
25th Feb 20227:37 amEQSHelios Underwriting (HUW): Initiation - Increased Lloyd's participation at the right time
10th Jan 20228:56 amRNSAcquisition
4th Jan 20227:00 amRNSDirector/PDMR Shareholding
4th Jan 20227:00 amRNSTotal Voting Rights
22nd Dec 20217:01 amRNS2022 Helios Retained Capacity
22nd Dec 20217:00 amRNSAcquisition of further Limited Liability Vehicles
20th Dec 20217:00 amRNSAcquisition, Issue of Equity & Total Voting Rights
6th Dec 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20217:00 amRNSAcquisition of further Limited Liability Vehicles
1st Dec 20212:31 pmRNSTotal Voting Rights
26th Nov 20217:00 amRNSQuarterly Syndicate Mid-point Forecasts
22nd Nov 20217:00 amRNSDirector/PDMR Shareholding
17th Nov 20217:00 amRNSAcquisition of Shareholding, Issue of Equity & TVR
15th Nov 202111:27 amRNSCapacity Value Update
15th Nov 20217:00 amRNSDirector/PDMR Shareholding
11th Nov 20217:00 amRNSAcquisition of further Limited Liability Vehicles
8th Nov 20217:00 amRNSDirector/PDMR Shareholding
18th Oct 20217:00 amRNSDirector/PDMR Shareholding
8th Oct 20217:00 amRNSAcquisition of further Limited Liability Vehicles
4th Oct 20217:00 amRNSAcquisition of Further Limited Liability Vehicles
30th Sep 20217:00 amRNSHalf-year Report
23rd Sep 20217:00 amRNSAcquisition of Limited Liability Vehicles
22nd Sep 20217:00 amRNSAcquisition, Issue of Equity & Total Voting Rights
20th Aug 20217:00 amRNSQuarterly Syndicate Mid-point Forecasts
17th Aug 20217:00 amRNSIssue of Equity and Director/PDMR Shareholding
28th Jul 20217:00 amRNSDirector/PCA Shareholding
29th Jun 20211:32 pmRNSResult of AGM
16th Jun 20217:00 amRNSUpdate re AGM
2nd Jun 20217:00 amRNSDirector/PCA Shareholding
1st Jun 20212:21 pmRNSDividend Declaration
28th May 20217:00 amRNSFinal Results for the year ended 31 December 2020
18th May 20212:30 pmEQSHardman & Co Investor Forum research: Helios Underwriting (HUW): Timing its growth with the insurance cycle
14th May 20217:00 amRNSQuarterly Syndicate Mid-point Forecasts
11th May 20217:00 amRNSHolding(s) in Company
27th Apr 202112:57 pmEQSHardman & Co Research : Hardman & Co Video Event | Helios Underwriting Plc - Investor Forum
27th Apr 20217:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.